Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › California › Glendale
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Glendale, CA keessatti
Qorannoo 9 Kansara Qara'a Non-Small Cell f Glendale fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Namoota walitti qabaa jiraSadarkaa 2/3
- Los Angeles Cancer Network, Glendale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Oncura Health - Corporate (Central IDS & Regulatory Only), Glendale
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Los Angeles Cancer Network, Glendale
- Glendale Adventist Medical Center, Glendale
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Namoota walitti qabaa jiraSadarkaa 1/2
- OPN Healthcare, Inc, Glendale
Pan-tumor MRD Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Los Angeles Cancer Network (LACN), Glendale
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Namoota walitti qabaa jiraSadarkaa 3
- Oncura Health d.b.a.Los Angeles Cancer Network, Glendale
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Namoota walitti qabaa jiraSadarkaa 3
- OPN Healthcare, Inc., Glendale
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Namoota walitti qabaa jiraSadarkaa 1/2
- Los Angeles Cancer Network, Glendale
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- OPN Healthcare, Inc., Glendale
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Glendale keessatti
- Dhibee Gaddii GuddaaQorannoo 12
- DepreshiniiQorannoo 6
- Saree (Gosoota Hunda)Qorannoo 5
- ObesityQorannoo 5
- Saree OljooQorannoo 4
- Kansarii ColorectalQorannoo 4
- Dhibee QaraQorannoo 4
- Kansara MetastatikiiQorannoo 3
- Dhukkuba Arterii KoronariyaaQorannoo 3
- MelanomaQorannoo 3
- Edema MakulaariiQorannoo 3
- Baayyee UlfaataaQorannoo 3
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.